Global Leukemia Treatment Drugs Market Research Report 2023

Report ID: 1974707 | Published Date: Jan 2025 | No. of Page: 82 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Leukemia Treatment Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Gleevec
        1.2.3 Sapacitabine
        1.2.4 GA101
        1.2.5 Vasaroxine
        1.2.6 Tosedosat
        1.2.7 Revlimid
        1.2.8 Bosutinib
    1.3 Market by Application
        1.3.1 Global Leukemia Treatment Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Research Institutes
        1.3.4 Diagnostic Centers
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Leukemia Treatment Drugs Market Perspective (2017-2028)
    2.2 Leukemia Treatment Drugs Growth Trends by Region
        2.2.1 Leukemia Treatment Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Leukemia Treatment Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Leukemia Treatment Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Leukemia Treatment Drugs Market Dynamics
        2.3.1 Leukemia Treatment Drugs Industry Trends
        2.3.2 Leukemia Treatment Drugs Market Drivers
        2.3.3 Leukemia Treatment Drugs Market Challenges
        2.3.4 Leukemia Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Leukemia Treatment Drugs Players by Revenue
        3.1.1 Global Top Leukemia Treatment Drugs Players by Revenue (2017-2022)
        3.1.2 Global Leukemia Treatment Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Leukemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Leukemia Treatment Drugs Revenue
    3.4 Global Leukemia Treatment Drugs Market Concentration Ratio
        3.4.1 Global Leukemia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Leukemia Treatment Drugs Revenue in 2021
    3.5 Leukemia Treatment Drugs Key Players Head office and Area Served
    3.6 Key Players Leukemia Treatment Drugs Product Solution and Service
    3.7 Date of Enter into Leukemia Treatment Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Leukemia Treatment Drugs Breakdown Data by Type
    4.1 Global Leukemia Treatment Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Leukemia Treatment Drugs Forecasted Market Size by Type (2023-2028)
5 Leukemia Treatment Drugs Breakdown Data by Application
    5.1 Global Leukemia Treatment Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Leukemia Treatment Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Leukemia Treatment Drugs Market Size (2017-2028)
    6.2 North America Leukemia Treatment Drugs Market Size by Country (2017-2022)
    6.3 North America Leukemia Treatment Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Leukemia Treatment Drugs Market Size (2017-2028)
    7.2 Europe Leukemia Treatment Drugs Market Size by Country (2017-2022)
    7.3 Europe Leukemia Treatment Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Leukemia Treatment Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Leukemia Treatment Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Leukemia Treatment Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Leukemia Treatment Drugs Market Size (2017-2028)
    9.2 Latin America Leukemia Treatment Drugs Market Size by Country (2017-2022)
    9.3 Latin America Leukemia Treatment Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Leukemia Treatment Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Leukemia Treatment Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Leukemia Treatment Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 GSK
        11.1.1 GSK Company Detail
        11.1.2 GSK Business Overview
        11.1.3 GSK Leukemia Treatment Drugs Introduction
        11.1.4 GSK Revenue in Leukemia Treatment Drugs Business (2017-2022)
        11.1.5 GSK Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Leukemia Treatment Drugs Introduction
        11.2.4 Pfizer Revenue in Leukemia Treatment Drugs Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 Novartis AG
        11.3.1 Novartis AG Company Detail
        11.3.2 Novartis AG Business Overview
        11.3.3 Novartis AG Leukemia Treatment Drugs Introduction
        11.3.4 Novartis AG Revenue in Leukemia Treatment Drugs Business (2017-2022)
        11.3.5 Novartis AG Recent Development
    11.4 Roche
        11.4.1 Roche Company Detail
        11.4.2 Roche Business Overview
        11.4.3 Roche Leukemia Treatment Drugs Introduction
        11.4.4 Roche Revenue in Leukemia Treatment Drugs Business (2017-2022)
        11.4.5 Roche Recent Development
    11.5 Celgene
        11.5.1 Celgene Company Detail
        11.5.2 Celgene Business Overview
        11.5.3 Celgene Leukemia Treatment Drugs Introduction
        11.5.4 Celgene Revenue in Leukemia Treatment Drugs Business (2017-2022)
        11.5.5 Celgene Recent Development
    11.6 Biogen
        11.6.1 Biogen Company Detail
        11.6.2 Biogen Business Overview
        11.6.3 Biogen Leukemia Treatment Drugs Introduction
        11.6.4 Biogen Revenue in Leukemia Treatment Drugs Business (2017-2022)
        11.6.5 Biogen Recent Development
    11.7 Genzyme Corporation
        11.7.1 Genzyme Corporation Company Detail
        11.7.2 Genzyme Corporation Business Overview
        11.7.3 Genzyme Corporation Leukemia Treatment Drugs Introduction
        11.7.4 Genzyme Corporation Revenue in Leukemia Treatment Drugs Business (2017-2022)
        11.7.5 Genzyme Corporation Recent Development
    11.8 Eisai C.
        11.8.1 Eisai C. Company Detail
        11.8.2 Eisai C. Business Overview
        11.8.3 Eisai C. Leukemia Treatment Drugs Introduction
        11.8.4 Eisai C. Revenue in Leukemia Treatment Drugs Business (2017-2022)
        11.8.5 Eisai C. Recent Development
    11.9 Bristol Myers Squibb Company (BMS)
        11.9.1 Bristol Myers Squibb Company (BMS) Company Detail
        11.9.2 Bristol Myers Squibb Company (BMS) Business Overview
        11.9.3 Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Introduction
        11.9.4 Bristol Myers Squibb Company (BMS) Revenue in Leukemia Treatment Drugs Business (2017-2022)
        11.9.5 Bristol Myers Squibb Company (BMS) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Leukemia Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Gleevec
    Table 3. Key Players of Sapacitabine
    Table 4. Key Players of GA101
    Table 5. Key Players of Vasaroxine
    Table 6. Key Players of Tosedosat
    Table 7. Key Players of Revlimid
    Table 8. Key Players of Bosutinib
    Table 9. Global Leukemia Treatment Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Leukemia Treatment Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Leukemia Treatment Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Leukemia Treatment Drugs Market Share by Region (2017-2022)
    Table 13. Global Leukemia Treatment Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Leukemia Treatment Drugs Market Share by Region (2023-2028)
    Table 15. Leukemia Treatment Drugs Market Trends
    Table 16. Leukemia Treatment Drugs Market Drivers
    Table 17. Leukemia Treatment Drugs Market Challenges
    Table 18. Leukemia Treatment Drugs Market Restraints
    Table 19. Global Leukemia Treatment Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Leukemia Treatment Drugs Market Share by Players (2017-2022)
    Table 21. Global Top Leukemia Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Treatment Drugs as of 2021)
    Table 22. Ranking of Global Top Leukemia Treatment Drugs Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Leukemia Treatment Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Leukemia Treatment Drugs Product Solution and Service
    Table 26. Date of Enter into Leukemia Treatment Drugs Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Leukemia Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Leukemia Treatment Drugs Revenue Market Share by Type (2017-2022)
    Table 30. Global Leukemia Treatment Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Leukemia Treatment Drugs Revenue Market Share by Type (2023-2028)
    Table 32. Global Leukemia Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Leukemia Treatment Drugs Revenue Market Share by Application (2017-2022)
    Table 34. Global Leukemia Treatment Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Leukemia Treatment Drugs Revenue Market Share by Application (2023-2028)
    Table 36. North America Leukemia Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Leukemia Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Leukemia Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Europe Leukemia Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Asia-Pacific Leukemia Treatment Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 41. Asia-Pacific Leukemia Treatment Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 42. Latin America Leukemia Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Latin America Leukemia Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Middle East & Africa Leukemia Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Middle East & Africa Leukemia Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 46. GSK Company Detail
    Table 47. GSK Business Overview
    Table 48. GSK Leukemia Treatment Drugs Product
    Table 49. GSK Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 50. GSK Recent Development
    Table 51. Pfizer Company Detail
    Table 52. Pfizer Business Overview
    Table 53. Pfizer Leukemia Treatment Drugs Product
    Table 54. Pfizer Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 55. Pfizer Recent Development
    Table 56. Novartis AG Company Detail
    Table 57. Novartis AG Business Overview
    Table 58. Novartis AG Leukemia Treatment Drugs Product
    Table 59. Novartis AG Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 60. Novartis AG Recent Development
    Table 61. Roche Company Detail
    Table 62. Roche Business Overview
    Table 63. Roche Leukemia Treatment Drugs Product
    Table 64. Roche Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 65. Roche Recent Development
    Table 66. Celgene Company Detail
    Table 67. Celgene Business Overview
    Table 68. Celgene Leukemia Treatment Drugs Product
    Table 69. Celgene Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 70. Celgene Recent Development
    Table 71. Biogen Company Detail
    Table 72. Biogen Business Overview
    Table 73. Biogen Leukemia Treatment Drugs Product
    Table 74. Biogen Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 75. Biogen Recent Development
    Table 76. Genzyme Corporation Company Detail
    Table 77. Genzyme Corporation Business Overview
    Table 78. Genzyme Corporation Leukemia Treatment Drugs Product
    Table 79. Genzyme Corporation Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 80. Genzyme Corporation Recent Development
    Table 81. Eisai C. Company Detail
    Table 82. Eisai C. Business Overview
    Table 83. Eisai C. Leukemia Treatment Drugs Product
    Table 84. Eisai C. Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 85. Eisai C. Recent Development
    Table 86. Bristol Myers Squibb Company (BMS) Company Detail
    Table 87. Bristol Myers Squibb Company (BMS) Business Overview
    Table 88. Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Product
    Table 89. Bristol Myers Squibb Company (BMS) Revenue in Leukemia Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 90. Bristol Myers Squibb Company (BMS) Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Leukemia Treatment Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Gleevec Features
    Figure 3. Sapacitabine Features
    Figure 4. GA101 Features
    Figure 5. Vasaroxine Features
    Figure 6. Tosedosat Features
    Figure 7. Revlimid Features
    Figure 8. Bosutinib Features
    Figure 9. Global Leukemia Treatment Drugs Market Share by Application in 2021 & 2028
    Figure 10. Hospitals Case Studies
    Figure 11. Research Institutes Case Studies
    Figure 12. Diagnostic Centers Case Studies
    Figure 13. Others Case Studies
    Figure 14. Leukemia Treatment Drugs Report Years Considered
    Figure 15. Global Leukemia Treatment Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global Leukemia Treatment Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Leukemia Treatment Drugs Market Share by Region: 2021 VS 2028
    Figure 18. Global Leukemia Treatment Drugs Market Share by Players in 2021
    Figure 19. Global Top Leukemia Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Treatment Drugs as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by Leukemia Treatment Drugs Revenue in 2021
    Figure 21. North America Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. North America Leukemia Treatment Drugs Market Share by Country (2017-2028)
    Figure 23. United States Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Leukemia Treatment Drugs Market Share by Country (2017-2028)
    Figure 27. Germany Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Leukemia Treatment Drugs Market Share by Region (2017-2028)
    Figure 35. China Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Leukemia Treatment Drugs Market Share by Country (2017-2028)
    Figure 43. Mexico Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Brazil Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa Leukemia Treatment Drugs Market Share by Country (2017-2028)
    Figure 47. Turkey Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Saudi Arabia Leukemia Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. GSK Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
    Figure 50. Pfizer Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
    Figure 51. Novartis AG Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
    Figure 52. Roche Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
    Figure 53. Celgene Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
    Figure 54. Biogen Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
    Figure 55. Genzyme Corporation Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
    Figure 56. Eisai C. Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
    Figure 57. Bristol Myers Squibb Company (BMS) Revenue Growth Rate in Leukemia Treatment Drugs Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GSK
Pfizer
Novartis AG
Roche
Celgene
Biogen
Genzyme Corporation
Eisai C.
Bristol Myers Squibb Company (BMS)
Frequently Asked Questions
Leukemia Treatment Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Leukemia Treatment Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Leukemia Treatment Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Lubricating Oil

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More